Usama, Julpa A.

HRN: 03-59-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/07/2026
04/13/2026
IV
300 MG
Q8
CELLULITIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines